Downregulation of COX-2 and iNOS by amentoflavone and quercetin in A549 human lung adenocarcinoma cell line

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 66, Issue 5-6, 2002, Pages 485-492

  Banerjee, T ^a   Van der Vliet, A ^a   Ziboh, V A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMENTOFLAVONE; CYCLOOXYGENASE 2; FLAVANONE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; QUERCETIN;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION;

EID: 0036586887     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2002.0387     Document Type: Article

References (67)

1. Duthie S. J., Dobson V. L. Dietary flavonoids protect human colonocyte DNA from oxidative attack in vitro. Eur J Nutr 1999; 38: 28-34.
2. Williamson G., Faulkner K., Plumb G.W. Glucosinolates and phenolics as oxidants from plant foods. Eur J Cancer Prev 1998; 7: 17-21.
3. Calomme M., Pieters L., Vlietinck A., Vanden Berghe D. Inhibition of external mutagenesis by citrus flavonoids. Planta Med 1996; 62: 222-226.
4. Plaumann B., Fritsche M., Rimpler H., Brandner G., Hess R. D. Flavonoids activate wild-type p53. Oncogene 1996; 13: 1605-1614.
5. Gerritsen M. E. Flavonoids: inhibitors of cytokine induced gene expression. Adv Exp Med Biol 1998; 439: 183-190.
6. Laughton M. J., Evans P. J., Moroney M. A., Hoult J. R., Halliwell B. Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and iron-ion reducing ability. Biochem Pharmacol 1991; 42: 1673-1681.
7. Ferrandiz M. L., Alcaraz M. J. Anti-inflammatory activity and inhibition of arachidonic acid metabolism by flavonoids. Agents Actions 1991; 32: 283-288.
8. Yoshimoto T., Furukawa M., Yamamoto S., Horie T., Watanbe-Kohno S. Flavonoids: potent inhibitors of arachidonate 5-lipoxygenase. Biochem Biophys Res Commun 1983; 116: 612-618.
9. Damas J., Bourdon V., Remacle-Volon G., Leconte J. Proinflammatory flavonoids which are inhibitors of prostaglandin synthesis. Prostaglandins Leukot Med 1985; 19: 11-24.
10. Wang H. K., Xla Y., Yang Z.Y., Natschke S. L., Lee K. H. Recent advances in the discovery and development of flavonoids and their analogues as antitumors and anti-HIV agents. Adv Exp Med Biol 1998; 439: 191-225.
11. Bae E. A., Han M. J., Lee M., Kim D. H. In vitro inhibitory effect of some flavonoids on rotavirus infectivity. Biol Pharm Bull 2000; 25: 1123-1124.
12. Hertog M. G. L., Feskens E. J. M., Hollman P. C. H., Katan M. B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993; 342: 1007-1011.
13. Peralta C., Rull R., Rimola A., et al. Endogenous nitric oxide and exogenous nitric oxide supplementation in hepatic ischemia-reperfusion in the rat. Transplantation 2001; 71: 529-536.
14. Halliwell B., Gutheridge J. M. C. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990; 186: 1-85.
15. Takemura R., Werb Z. Secretory products of macrophages and their physiological functions. Am J Physiol 1984; 246: C1-C9.
16. Nathan C. F. Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest 1987; 79: 319-326.
17. Oh T., Lee J., Ahn B., et al. Oxidative damages are critical in pathogenesis of reflux esophagitis: implication of antioxidants in its treatment. Free Radio Biol Med 2001; 30: 905-915.
18. Bai Y., Suzuki A. K., Sagai M. The cytotoxic effects of diesel exhaust particles on human pulmonary artery endothelial cells in vitro: role of active oxygen species. Free Radio Biol Med 2001; 30: 555-562.
19. Beckman J. S., Ye Y. Z., Anderson P. G., et al. Extensive nitration of protein tyrosines in human atheroscerosis detected by immunohistochemistry. Biol Chem Hoppe-Seyler 1994; 375: 81-88.
20. Onoda M., Inano H. Effect of curcumin on the production of nitric oxide by cultured rat mammary gland. Nitric Oxide 2000; 4: 505-515.
21. 2+ ions: implications for their antioxidant properties. Biochem J 1998; 330: 1173-1178.
22. Chang W. S., Lee Y. J., Lu F. J., Chiang H. C. Inhibitory effects of flavonoids on xanthine oxidase. Anticancer Res 1993; 13: 2165-2170.
23. Rohnert U., Schneider W., Elstner E. F. Superoxide-dependent and independent nitrite formation hydroxylamine: inhibition by plant extracts. Z Naturforsch 1998; 53: 241-249.
24. van Acker S. A. B. E., van Balan G. P., Van der Berg D. J., Bast A., Van der Vijgh W. J. Influence of iron chelation on the antioxidant activity of flavonoids. Biochem Pharmacol 1998; 56: 935-943.
25. Van Acker S. A. B. E., Tromp M. N. J. K., Haenen G. R. M. M., Van der Vijgh W. J., Bast A. Flavonoids as scavengers of nitric oxide radical. Biochem Biophys Res Commun 1995; 214: 755-759.
26. Knekt P., Jarvinen R., Seppanew R. Dietary flavonoids and the risk of lung cancer and other malignant neoplasm. Am J Epidemiol 1997; 146: 223-230.
27. Deschener F. E., Ruperto J., Wong G., Newmark H. L. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis 1991; 16: 1193-1196.
28. Kuntz S., Wenzel U., Daniel H. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity and apoptosis in human colon cancer cell lines. Eur J Nutr 1999; 38: 133-142.
29. Rodgers E. H., Grant M. H. The effect of the flavonoids, quercetin, myricetin and epicatecin on the growth and enzyme activities of MCF7 human breast cancer cells. Chem Biol Interact 1998; 116: 213-228.
30. Matsumoto N., Kohri T., Okushio K., Hara Y. Inhibitory effects of tea catechins, black tea extract and oolong tea extract on hepatocarcinogenesis in rat. Jpn J Cancer Res 1996; 87: 1034-1038.
31. Fukai T., Sakagami H., Toguchi M., et al. Cytotoxic activity of low molecular weight polyphenols against human oral tumors cell lines. Anticancer Res 2000; 20: 2525-2536.
32. Bhatia N., Agarwal R. Detrimental effect of cancer preventive phytochemicals sillymarin, genistein and epigallocatechin 3-gallate on epigenetic events in human prostate carcinoma DUI45 cells. The Prostate 2001; 46: 98-107.
33. Seed M. P. Angiogenesis inhibition as a drug target for disease: an update. Exp Opin Invest Drugs 1996; 5: 1617-1637.
34. Levy G. N. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs and colon cancer. FASEB J 1997; 11: 234-247.
35. Herschman H. R. Prostaglandin synthase 2. Biochim Biophys Acta 1996; 1299: 125-140.
36. Needleman P., Turk J., Jakschik B. A., Morrison A. R., Lefkowith J. B. Arachidonic acid metabolism. Ann Rev Biochem 1986; 55: 69-102.
37. Oshima M., Dinchuk J. E., Kargman S. L., et al. Suppression of intestinal polyposis in Ape delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996; 87: 803-809.
38. Dubois R. N., Abramson S. B., Crafford L., et al. Cyclooxygenase in biology nad disease. FASEB J 1998; 12: 1063-1073.
39. Vane J. R., Mitchell J. A., Appleton I., et al. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci USA 1994; 91: 2046-2050.
40. Ambs S., Hussain S. P., Marrogi A. J., Harris C. C. Cancer-prone oxyradical overload disease. IARC Sci Publ 1999; 150: 295-302.
41. Salvemini D., Seibert K., Masferrer J. L., Misk T. P., Currie M. G., Needleman P. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Invest 1994; 93: 1940-1947.
42. Sautebin L., Di Rosa M. Nitric oxide modulates prostacyclin biosynthesis in the lung of endotoxin-treated rats. Eur J Pharmacol 1994; 262: 193-196.
43. Form D. M., Auerbach R. PGE2 and angiogenesis. Proc Soc Exp Biol Med 1983; 172: 214-218.
44. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-364.
45. Masferrer J. L., Koki A. T., Siebert K. COX-2 inhibitors. A new class of antiangiogenic agents. Ann NY Acad Sci 1999; 889: 84-86.
46. Kim H. K., Cheon B. S., Kim Y. H., Kim S. Y., Kim H. P. Effects of naturally occuring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationship. Biochem Pharmacol 1999; 58: 759-765.
47. Chen Y.-C., Yang L-L., Lee T. J-F. Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-κB activation. Biochem Pharmacol 2000; 59: 1445-1457.
48. Soliman K. F., Mazzio E. A. In vitro attenuation of nitric oxide production in C6 astrocyte cell culture by dietary compounds. Proc Soc Exp Biol Med 1998; 218: 390-397.
49. Mutoh M., Takahashi M., Fukuda K., et al. Suppression by flavonoids of cyclooxygenase-2 promoter dependent transcriptional activity in colon cancer cells: structure-activity relationship. Jpn J Cancer Res 2001; 91: 686-691.
50. Kim H. P., Mani I., Iverson L., Ziboh V. A. Effects of naturally-occuring flavonoids and biflavonoids on epidermal cycloxygenase and lipoxygenase from guinea-pigs. Prostaglandins Leukot Essent Fatty Acids 1998; 58: 17-24.
51. Hernandez M., Bayon Y., Sanchez C., Maria Luisa N. J. Signaling mechanisms involved in the activation of arachidonic acid metabolism in human astrocytoma cells by tumor necrosis factor alpha; phosphorylation of cytosolic phospholipase A2 and transactivation of cyclooxygenase-2. Neurochem 1999; 73: 1641-1649.
52. Braman R. S., Hendrix S. A. Nanogram nitrite and nitrate determination in environmental and biological materials by vanadium (III) reduction with chemiluminescence detection. Anal Chem 1989; 61: 2715-2718.
53. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
54. Corbett J. A., Kwon G., Turk J., McDaniel M. L. IL-1beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cycloxygenase by nitric oxide. Biochemistry 1993; 32: 13767-13770.
55. Inoue T., Fukuo K., Morimoto S., Koh E., Ogihara T. Nitric oxide mediates interleukin-1 induced protaglandin E2 production by vascular smooth muscle cells. Biochem Biophys Res Commun 1993; 194: 420-424.
56. Tetsuka T., Daphna-Iken D., Srivastava S. K., Baier L. D., Du Maine J., Morrison A. R. Cross-talk between cycloxygenase and nitric oxide pathways: prostaglandin E2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc Natl Acad Sci USA 1994; 91: 12168-12172.
57. Molina-Holgado F., Lledo A., Guaza C. Evidence for cycloxygenase activation by nitric oxide in astrocytes. Glia (United States) 1995; 15: 167-172.
58. Ferriola P. C., Cody V., Middleton E. Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationship. Biochem Pharmacol 1989; 38: 1617-1626.
59. Agullo G., Gamet-Payrastre L., Manteni S., et al. Relationship between flavonoid structure and inhibition of phosphotidylinositol 3 kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 1997; 53: 1649-1657.
60. Lee H. S., Oh W. K., Kim B. Y., et al. Inhibition of phospholipase C gamma 1 by the prenylated flavonoids from Sophora flavescens. Planta Med 1996; 62: 293-296.
61. Kim H. K., Son K. H., Chang H. W., Kang S. S. and Kim H. P. Amentoflavone, a plant biflavone: a new potential anti-inflammatory agent. Arch Pharm Res 1998; 21: 406-410.
62. Watkins D. N., Garlepp M. J., Thompson P. J. Regulation of the inducible cyclooxygenase pathway in human cultured airway epithelial (A549) cells by nitric oxide. Br J Pharmacol 1997; 121: 1482-1488.
63. Tsujii M., Kawano S., Tsuji S., Sawaoka H., Hori M., Dubois R. N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998; 93: 705-716.
64. Sheng H., Williams C. S., Shao J., Liang P., Dubois R. N., Beauchamp R. D. Induction of cyclooxygenase-2 by activated Haras oncogene in rat fibroblasts and the role of mitogen activated protein kinase pathway. J Biol Chem 1998; 273: 22120-22127.
65. Tsujii M., Dubois R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995; 83: 493-501.
66. Tsujii M., Kawano S., Dubois R. N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997; 94: 3336-3340.
67. Huang M., Stolina M., Sharma S., et al. Non-small cell lung cancer cyclooxygenase 2 dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res 1998; 58: 1208-1216.